Loading…
Loading…
Is this the right time for a share buyback or otherwise a return of capital to shareholders
We've seen some third-party data that suggests that LEQEMBI may be losing a little bit of share in the U.S. So wonder if you might comment on the competitive dynamic
Are we going to see any additional phase one two data in 2026? And does the pivotal study have an interim analysis